Neophar Pharmaceuticals Private Limited
About Neophar Pharmaceuticals Private Limited
Data last updated:
Neophar Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 19 October 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2023PTC421633.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Kumar and Ruby Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 221 Ground Floor Pkt H, Sector – 1 Bawana Delhi, Delhi, India – 110039.
Company details
Contact details
Neophar Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressPlot No 221 Ground Floor Pkt H, Sector – 1 Bawana Delhi, Delhi, India – 110039
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Neophar Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Neophar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neophar Pharmaceuticals Private Limited
Neophar Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
| Ruby Rani | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Neophar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neophar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neophar Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neophar Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Manish Kumar was appointed as Director on 19 Oct 2023.
Frequently asked questions
Neophar Pharmaceuticals is an active private limited company based in Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 19 October 2023 (3+ years old) and is registered under CIN U21001DL2023PTC421633.
Neophar Pharmaceuticals has 2 current directors:
- Manish Kumar - Director
- Ruby Rani - Director
The latest financial statements of Neophar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Neophar Pharmaceuticals is U21001DL2023PTC421633. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neophar Pharmaceuticals was incorporated on 19 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Manish Kumar was appointed as Director on 19 Oct 2023. Ruby Rani was appointed as Director on 19 Oct 2023.
The registered office of Neophar Pharmaceuticals is at Plot No 221 Ground Floor Pkt H, Sector – 1 Bawana Delhi, Delhi, India – 110039.
Neophar Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Neophar Pharmaceuticals can be reached at its registered office: Plot No 221 Ground Floor Pkt H, Sector – 1 Bawana Delhi, Delhi, India – 110039.
Neophar Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
